Jie Dong
-
- MicroRNA in disease regulation 2
-
- Renal cell carcinoma treatment 12
- Prostate Cancer Diagnosis and Treatment 3
- Gastric Cancer Management and Outcomes 3
- Renal and Vascular Pathologies 3
-
- Colorectal Cancer Screening and Detection 2
-
- Renal and related cancers 8
-
- Bladder and Urothelial Cancer Treatments 6
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)Molecular Biology and Evolution (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jie Dong
36 papers receiving 463 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 115
- Pulmonary and Respiratory Medicine 114
- Aging 6
- Oncology 88
- Molecular Biology 171
Countries citing papers authored by Jie Dong
This map shows the geographic impact of Jie Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Dong more than expected).
Fields of papers citing papers by Jie Dong
This network shows the impact of papers produced by Jie Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Dong. The network helps show where Jie Dong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 4 | |
| 15 | 2018 | 22 | |
| 16 | 2016 | 17 | |
| 17 | 2015 | 0 | |
| 18 | 2013 | 5 | |
| 19 | 2011 | 123 | |
| 20 | 2008 | 64 |
About Jie Dong
Jie Dong is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology, having authored 43 papers that have together received 466 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), Renal and related cancers (8 papers), Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers), Renal and Vascular Pathologies (3 papers), Colorectal Cancer Screening and Detection (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (115 citations), Pulmonary and Respiratory Medicine (114 citations) and Aging (6 citations). Jie Dong has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yupei Zhao, Taiping Zhang, Ge Chen, Li Zhou, Weifeng Xu, Leyuan Ma, Pang YaoShan, Xudong Liu, Decheng Wang and Sufang Chen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Biology and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.